Bank Of New York Mellon Corp Instil Bio, Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.6 - $0.91 $144,757 - $219,548	241,262 New	241,262 $159 Million
Q4 2022 Feb 14, 2023	BUY	$0.48 - $5.33 $115,805 - $1.29 Million	241,262 New	241,262 $151,000
Q3 2022 Nov 14, 2022	BUY	$4.65 - $7.37 $233,992 - $370,865	50,321 Added 25.77%	245,557 $1.19 Million
Q2 2022 Aug 15, 2022	SELL	$4.21 - $11.15 $98,354 - $260,486	-23,362 Reduced 10.69%	195,236 $902,000
Q1 2022 May 11, 2022	SELL	$8.48 - $18.1 $54,806 - $116,980	-6,463 Reduced 2.87%	218,598 $2.35 Million
Q4 2021 Feb 11, 2022	BUY	$15.37 - $22.5 $1.5 Million - $2.2 Million	97,805 Added 76.86%	225,061 $3.85 Million
Q3 2021 Nov 12, 2021	BUY	$15.05 - $23.28 $133,523 - $206,540	8,872 Added 7.49%	127,256 $2.28 Million
Q2 2021 Aug 11, 2021	BUY	$15.31 - $24.63 $1.4 Million - $2.26 Million	91,709 Added 343.8%	118,384 $2.29 Million
Q1 2021 May 13, 2021	BUY	$24.23 - $27.06 $646,335 - $721,825	26,675 New	26,675 $669,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.67B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.